Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1992 | 03-1992 | 12-1991 | 06-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,757 | 5,079 | N/A | 87 | 87 |
| Inventories | 7 | 10 | N/A | 10 | 10 |
| Other current assets | 58 | 68 | 0 | 29 | 29 |
| TOTAL | $4,823 | $5,156 | $N/A | $126 | $126 |
| Non-Current Assets | |||||
| PPE Net | 29 | 24 | N/A | 19 | 19 |
| Other Non-Current Assets | 5 | 6 | 0 | 24 | 24 |
| TOTAL | $34 | $29 | $N/A | $44 | $44 |
| Total Assets | $4,850 | $5,184 | $N/A | $167 | $167 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 154 | 213 | 0 | 10 | 10 |
| TOTAL | $154 | $213 | $N/A | $10 | $10 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $154 | $213 | $N/A | $10 | $10 |
| Shareholders' Equity | |||||
| Common Shares | 5,592 | 5,527 | N/A | 319 | 319 |
| Retained earnings | -990 | -717 | N/A | -256 | -256 |
| Other shareholders' equity | 0 | 67 | 0 | 0 | 0 |
| TOTAL | $4,696 | $4,971 | $N/A | $158 | $158 |
| Total Liabilities And Equity | $4,850 | $5,184 | $0 | $167 | $167 |